Merge Healthcare, Inc. recalls Merge Hemo software. Product Usage: Merge Hemo is a hemodynamic monitoring system that records and displays physiologic…
- Recall date
- April 4, 2016
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- Z-1457-2017
- FDA classification
- Class II
- Brand / firm
- Merge Healthcare, Inc.
- Sold / distributed
- US Nationwide Distribution.
Why it was recalled
In some instances, the system will lock tabs within a study, even when a second user does not have the study open on a different workstation.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Merge Hemo software. Product Usage: Merge Hemo is a hemodynamic monitoring system that records and displays physiological data.
Get recall alerts
Free email alert whenever Merge Healthcare, Inc. has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Merge Healthcare, Inc.